EVENT TB
Research type
Research Study
Full title
Investigating Early Immunological Events in Active TB Disease and Latent Tuberculosis Infection (EVENT TB)
IRAS ID
277963
Contact name
Pranabashis Haldar
Contact email
Sponsor organisation
University of Leicester
Duration of Study in the UK
5 years, 0 months, 1 days
Research summary
Tuberculosis (TB) is a disease caused by bacteria called Mycobacterium tuberculosis (M. tuberculosis). TB usually affects the lungs and is increasing in the UK. It can result in serious illness and remains a major cause of death in the world. However, not everyone infected with M. tuberculosis becomes sick and exhibits features of active TB disease. Thus, there are two TB related conditions:
•Active TB disease and
•Latent TB infection (LTBI)Those with LTBI do not feel sick and do not have any symptoms, they are infected but not clinically affected. Currently, the diagnosis of LTBI is based solely on evidence of immune reaction, usually by positive blood test (QuantiFERON-TB Gold In-Tube). Overall, without treatment, about 10-20% of LTBI patients will develop active TB disease at some point in their lives, with most developing TB disease in the first two years of infection.
Clinically, there is no current test that can:
•differentiate active TB disease from LTBI or
•identify those with LTBI who may progress to active TB diseaseIdentification of those LTBI individuals most at risk of developing active TB disease would help clinicians to target preventative therapy. This is an important issue as disease treatment is lengthy with potentially toxic drugs.
To improve the detection and treatment of LTBI, we need a better understanding of how the immune system responds to it. This study aims to identify the patterns of gene activity that represent the immune response of patients with active TB disease and LTBI both systemically (from blood) and locally (from samples taken from the lungs).
REC name
East Midlands - Nottingham 1 Research Ethics Committee
REC reference
21/EM/0139
Date of REC Opinion
18 Jun 2021
REC opinion
Favourable Opinion